Los Angeles City Council recently highlighted the critical work of the USC Brain Tumor Center during a meeting dedicated to raising awareness about brain tumors. The center, which has become a beacon of hope for patients, is staffed by leading neurosurgeons, neuro-oncologists, and researchers focused on improving surgical techniques and patient care.

With an estimated one million Americans currently living with primary brain tumors, the urgency of this issue is clear. Malignant brain tumors are particularly deadly, boasting a mere 36 percent five-year survival rate. The council emphasized the profound impact these conditions have not only on patients but also on their families.

In recognition of May as Brain Tumor Awareness Month, the council showcased a video presentation detailing the center's innovative approach to treatment. The USC Brain Tumor Center offers a streamlined, executive-style navigated treatment plan, allowing patients to meet specialists, receive advanced imaging, and develop personalized care plans all in one day. This comprehensive approach is designed to alleviate the confusion and fear that often accompany a brain tumor diagnosis.

The center's commitment to personalized medicine includes developing immunotherapy treatments tailored to individual patients. By utilizing tumor cells from patients, the center can create vaccines and test chemotherapy options that minimize collateral damage, ensuring more effective treatment.

Since its launch five to six years ago, the USC Brain Tumor Center has expanded its clinical trials from two to over ten, reflecting its dedication to integrating the latest technologies in patient care. The council's recognition of this vital work underscores the importance of continued support for innovative medical research and treatment options for those affected by brain tumors.